These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
522 related items for PubMed ID: 1312898
21. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T. Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839 [Abstract] [Full Text] [Related]
22. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. Patten CJ, Smith TJ, Friesen MJ, Tynes RE, Yang CS, Murphy SE. Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639 [Abstract] [Full Text] [Related]
23. Quantitation of microsomal alpha-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Peterson LA, Mathew R, Hecht SS. Cancer Res; 1991 Oct 15; 51(20):5495-500. PubMed ID: 1913670 [Abstract] [Full Text] [Related]
24. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. Upadhyaya P, Kenney PM, Hochalter JB, Wang M, Hecht SS. Carcinogenesis; 1999 Aug 15; 20(8):1577-82. PubMed ID: 10426810 [Abstract] [Full Text] [Related]
25. Induction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise. Ardies CM, Smith TJ, Kim S, Yang CS. Cancer Lett; 1996 Jun 05; 103(2):209-18. PubMed ID: 8635159 [Abstract] [Full Text] [Related]
26. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes. Brown PJ, Bedard LL, Reid KR, Petsikas D, Massey TE. Drug Metab Dispos; 2007 Nov 05; 35(11):2086-94. PubMed ID: 17717079 [Abstract] [Full Text] [Related]
27. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Jalas JR, Ding X, Murphy SE. Drug Metab Dispos; 2003 Oct 05; 31(10):1199-202. PubMed ID: 12975327 [Abstract] [Full Text] [Related]
28. Effects of citrus phytochemicals on liver and lung cytochrome P450 activity and on the in vitro metabolism of the tobacco-specific nitrosamine NNK. Bear WL, Teel RW. Anticancer Res; 2000 Oct 05; 20(5A):3323-9. PubMed ID: 11062760 [Abstract] [Full Text] [Related]
29. Metabolic activation of the tobacco carcinogen 4-(methylnitrosamino)-(3-pyridyl)-1-butanone by cytochrome P450 2A13 in human fetal nasal microsomes. Wong HL, Zhang X, Zhang QY, Gu J, Ding X, Hecht SS, Murphy SE. Chem Res Toxicol; 2005 Jun 05; 18(6):913-8. PubMed ID: 15962925 [Abstract] [Full Text] [Related]
30. Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. He XY, Shen J, Ding X, Lu AY, Hong JY. Drug Metab Dispos; 2004 Dec 05; 32(12):1516-21. PubMed ID: 15333516 [Abstract] [Full Text] [Related]
31. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Hong JY, Wang ZY, Smith TJ, Zhou S, Shi S, Pan J, Yang CS. Carcinogenesis; 1992 May 05; 13(5):901-4. PubMed ID: 1587006 [Abstract] [Full Text] [Related]
32. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells. Smith GB, Castonguay A, Donnelly PJ, Reid KR, Petsikas D, Massey TE. Carcinogenesis; 1999 Sep 05; 20(9):1809-18. PubMed ID: 10469628 [Abstract] [Full Text] [Related]
33. 2'-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Hecht SS, Hochalter JB, Villalta PW, Murphy SE. Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12493-7. PubMed ID: 11050152 [Abstract] [Full Text] [Related]
34. Inhibition of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by dietary benzaldehydes. Morse MA, Kresty LA, Toburen AL. Cancer Lett; 1995 Nov 06; 97(2):255-61. PubMed ID: 7497471 [Abstract] [Full Text] [Related]
35. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats. Trushin N, Hecht SS. Chem Res Toxicol; 1999 Feb 06; 12(2):164-71. PubMed ID: 10027794 [Abstract] [Full Text] [Related]
36. Absence of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by flavin-containing monooxygenase (FMO). Lamoureux J, Castonguay A. Carcinogenesis; 1997 Oct 06; 18(10):1979-84. PubMed ID: 9364009 [Abstract] [Full Text] [Related]
37. Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: Sex difference, inducibility and inhibition by phenethylisothiocyanate. Schulze J, Malone A, Richter E. Carcinogenesis; 1995 Aug 06; 16(8):1733-40. PubMed ID: 7634397 [Abstract] [Full Text] [Related]
39. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Lacroix D, Desrochers M, Castonguay A, Anderson A. Carcinogenesis; 1993 Aug 15; 14(8):1639-42. PubMed ID: 8353848 [Abstract] [Full Text] [Related]
40. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue. Doerr-O'Rourke K, Trushin N, Hecht SS, Stoner GD. Carcinogenesis; 1991 Jun 15; 12(6):1029-34. PubMed ID: 2044181 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]